Found 464 hits with Last Name = 'rennie' and Initial = 'gr' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Hematopoietic prostaglandin D synthase
(Homo sapiens (Human)) | BDBM50385150
(CHEMBL2035650)Show SMILES FC(F)(F)CN1CCC(CC1)NC(=O)c1ccc(nc1)-c1ccccc1 Show InChI InChI=1S/C19H20F3N3O/c20-19(21,22)13-25-10-8-16(9-11-25)24-18(26)15-6-7-17(23-12-15)14-4-2-1-3-5-14/h1-7,12,16H,8-11,13H2,(H,24,26) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of HPGDS |
Bioorg Med Chem Lett 22: 3795-9 (2012)
Article DOI: 10.1016/j.bmcl.2012.04.004 BindingDB Entry DOI: 10.7270/Q28C9X82 |
More data for this Ligand-Target Pair | |
Hematopoietic prostaglandin D synthase
(Homo sapiens (Human)) | BDBM50385142
(CHEMBL2035651)Show InChI InChI=1S/C22H23N3O2/c26-22(24-11-12-25-13-15-27-16-14-25)19-7-5-18(6-8-19)21-20-4-2-1-3-17(20)9-10-23-21/h1-10H,11-16H2,(H,24,26) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL MMDB PC cid PC sid PDB UniChem
Similars
| PDB Article PubMed
| n/a | n/a | 2.34 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of human recombinant HPGDS using PGH2 as substrate assessed as production of PGD2 preincubated for 10 mins prior substrate addition measur... |
Bioorg Med Chem Lett 22: 3795-9 (2012)
Article DOI: 10.1016/j.bmcl.2012.04.004 BindingDB Entry DOI: 10.7270/Q28C9X82 |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323438
(4-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(n1)-c1cccc(CNC(=O)CCC(O)=O)c1 Show InChI InChI=1S/C29H31N5O4/c1-29(2,3)24-17-25(32-28(38)31-23-13-7-10-20-9-4-5-12-22(20)23)34(33-24)21-11-6-8-19(16-21)18-30-26(35)14-15-27(36)37/h4-13,16-17H,14-15,18H2,1-3H3,(H,30,35)(H,36,37)(H2,31,32,38) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Serine/threonine-protein kinase PLK1
(Homo sapiens (Human)) | BDBM26514
(4-{[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,...)Show SMILES CC[C@H]1N(C2CCCC2)c2nc(Nc3ccc(cc3)C(=O)NC3CCN(C)CC3)ncc2N(C)C1=O |r| Show InChI InChI=1S/C27H37N7O2/c1-4-22-26(36)33(3)23-17-28-27(31-24(23)34(22)21-7-5-6-8-21)30-19-11-9-18(10-12-19)25(35)29-20-13-15-32(2)16-14-20/h9-12,17,20-22H,4-8,13-16H2,1-3H3,(H,29,35)(H,28,30,31)/t22-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Pfizer
| Assay Description Percent inhibition and IC50 values were determined with ATP concentrations at apparent Km using the Invitrogen SelectScreen Kinase Profiling Service ... |
Chem Biol Drug Des 70: 540-6 (2007)
Article DOI: 10.1111/j.1747-0285.2007.00594.x BindingDB Entry DOI: 10.7270/Q2T151Z8 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323416
(2-acetamido-N-(3-(3-tert-butyl-5-(3-phenylureido)-...)Show SMILES CC(=O)NCC(=O)NCc1cccc(c1)-n1nc(cc1NC(=O)Nc1ccccc1)C(C)(C)C Show InChI InChI=1S/C25H30N6O3/c1-17(32)26-16-23(33)27-15-18-9-8-12-20(13-18)31-22(14-21(30-31)25(2,3)4)29-24(34)28-19-10-6-5-7-11-19/h5-14H,15-16H2,1-4H3,(H,26,32)(H,27,33)(H2,28,29,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323438
(4-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(n1)-c1cccc(CNC(=O)CCC(O)=O)c1 Show InChI InChI=1S/C29H31N5O4/c1-29(2,3)24-17-25(32-28(38)31-23-13-7-10-20-9-4-5-12-22(20)23)34(33-24)21-11-6-8-19(16-21)18-30-26(35)14-15-27(36)37/h4-13,16-17H,14-15,18H2,1-3H3,(H,30,35)(H,36,37)(H2,31,32,38) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of active p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Serine/threonine-protein kinase PLK3
(Homo sapiens (Human)) | BDBM26514
(4-{[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,...)Show SMILES CC[C@H]1N(C2CCCC2)c2nc(Nc3ccc(cc3)C(=O)NC3CCN(C)CC3)ncc2N(C)C1=O |r| Show InChI InChI=1S/C27H37N7O2/c1-4-22-26(36)33(3)23-17-28-27(31-24(23)34(22)21-7-5-6-8-21)30-19-11-9-18(10-12-19)25(35)29-20-13-15-32(2)16-14-20/h9-12,17,20-22H,4-8,13-16H2,1-3H3,(H,29,35)(H,28,30,31)/t22-/m1/s1 | PDB
NCI pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 6.70 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Pfizer
| Assay Description Percent inhibition and IC50 values were determined with ATP concentrations at apparent Km using the Invitrogen SelectScreen Kinase Profiling Service ... |
Chem Biol Drug Des 70: 540-6 (2007)
Article DOI: 10.1111/j.1747-0285.2007.00594.x BindingDB Entry DOI: 10.7270/Q2T151Z8 |
More data for this Ligand-Target Pair | |
Serine/threonine-protein kinase PLK1
(Homo sapiens (Human)) | BDBM25121
(4-{[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,...)Show SMILES CC[C@H]1N(C2CCCC2)c2nc(Nc3ccc(cc3OC)C(=O)NC3CCN(C)CC3)ncc2N(C)C1=O |r| Show InChI InChI=1S/C28H39N7O3/c1-5-22-27(37)34(3)23-17-29-28(32-25(23)35(22)20-8-6-7-9-20)31-21-11-10-18(16-24(21)38-4)26(36)30-19-12-14-33(2)15-13-19/h10-11,16-17,19-20,22H,5-9,12-15H2,1-4H3,(H,30,36)(H,29,31,32)/t22-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 8 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Pfizer
| Assay Description Percent inhibition and IC50 values were determined with ATP concentrations at apparent Km using the Invitrogen SelectScreen Kinase Profiling Service ... |
Chem Biol Drug Des 70: 540-6 (2007)
Article DOI: 10.1111/j.1747-0285.2007.00594.x BindingDB Entry DOI: 10.7270/Q2T151Z8 |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Hematopoietic prostaglandin D synthase
(Homo sapiens (Human)) | BDBM50385144
(CHEMBL2035653)Show SMILES Cc1cc2ccccc2c(n1)-c1ccc(cc1)C(=O)NCCN1CCOCC1 Show InChI InChI=1S/C23H25N3O2/c1-17-16-20-4-2-3-5-21(20)22(25-17)18-6-8-19(9-7-18)23(27)24-10-11-26-12-14-28-15-13-26/h2-9,16H,10-15H2,1H3,(H,24,27) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL MMDB PC cid PC sid PDB UniChem
Similars
| PDB Article PubMed
| n/a | n/a | 8.26 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of human recombinant HPGDS using PGH2 as substrate assessed as production of PGD2 preincubated for 10 mins prior substrate addition measur... |
Bioorg Med Chem Lett 22: 3795-9 (2012)
Article DOI: 10.1016/j.bmcl.2012.04.004 BindingDB Entry DOI: 10.7270/Q28C9X82 |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Serine/threonine-protein kinase PLK2
(Homo sapiens (Human)) | BDBM26514
(4-{[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,...)Show SMILES CC[C@H]1N(C2CCCC2)c2nc(Nc3ccc(cc3)C(=O)NC3CCN(C)CC3)ncc2N(C)C1=O |r| Show InChI InChI=1S/C27H37N7O2/c1-4-22-26(36)33(3)23-17-28-27(31-24(23)34(22)21-7-5-6-8-21)30-19-11-9-18(10-12-19)25(35)29-20-13-15-32(2)16-14-20/h9-12,17,20-22H,4-8,13-16H2,1-3H3,(H,29,35)(H,28,30,31)/t22-/m1/s1 | PDB
NCI pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 11.5 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Pfizer
| Assay Description Percent inhibition and IC50 values were determined with ATP concentrations at apparent Km using the Invitrogen SelectScreen Kinase Profiling Service ... |
Chem Biol Drug Des 70: 540-6 (2007)
Article DOI: 10.1111/j.1747-0285.2007.00594.x BindingDB Entry DOI: 10.7270/Q2T151Z8 |
More data for this Ligand-Target Pair | |
Serine/threonine-protein kinase PLK3
(Homo sapiens (Human)) | BDBM25121
(4-{[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,...)Show SMILES CC[C@H]1N(C2CCCC2)c2nc(Nc3ccc(cc3OC)C(=O)NC3CCN(C)CC3)ncc2N(C)C1=O |r| Show InChI InChI=1S/C28H39N7O3/c1-5-22-27(37)34(3)23-17-29-28(32-25(23)35(22)20-8-6-7-9-20)31-21-11-10-18(16-24(21)38-4)26(36)30-19-12-14-33(2)15-13-19/h10-11,16-17,19-20,22H,5-9,12-15H2,1-4H3,(H,30,36)(H,29,31,32)/t22-/m1/s1 | PDB
NCI pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 13.6 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Pfizer
| Assay Description Percent inhibition and IC50 values were determined with ATP concentrations at apparent Km using the Invitrogen SelectScreen Kinase Profiling Service ... |
Chem Biol Drug Des 70: 540-6 (2007)
Article DOI: 10.1111/j.1747-0285.2007.00594.x BindingDB Entry DOI: 10.7270/Q2T151Z8 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323437
((1R)-6-(3-(3-tert-butyl-5-(3-phenylureido)-1H-pyra...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)C2CC=CC[C@H]2C(O)=O)c1 |r,c:32| Show InChI InChI=1S/C29H33N5O4/c1-29(2,3)24-17-25(32-28(38)31-20-11-5-4-6-12-20)34(33-24)21-13-9-10-19(16-21)18-30-26(35)22-14-7-8-15-23(22)27(36)37/h4-13,16-17,22-23H,14-15,18H2,1-3H3,(H,30,35)(H,36,37)(H2,31,32,38)/t22?,23-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323427
(CHEMBL1209482 | N-(3-(3-tert-butyl-5-(3-phenylurei...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)Cn2ccccc2=O)c1 Show InChI InChI=1S/C28H30N6O3/c1-28(2,3)23-17-24(31-27(37)30-21-11-5-4-6-12-21)34(32-23)22-13-9-10-20(16-22)18-29-25(35)19-33-15-8-7-14-26(33)36/h4-17H,18-19H2,1-3H3,(H,29,35)(H2,30,31,37) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Serine/threonine-protein kinase PLK2
(Homo sapiens (Human)) | BDBM25121
(4-{[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,...)Show SMILES CC[C@H]1N(C2CCCC2)c2nc(Nc3ccc(cc3OC)C(=O)NC3CCN(C)CC3)ncc2N(C)C1=O |r| Show InChI InChI=1S/C28H39N7O3/c1-5-22-27(37)34(3)23-17-29-28(32-25(23)35(22)20-8-6-7-9-20)31-21-11-10-18(16-24(21)38-4)26(36)30-19-12-14-33(2)15-13-19/h10-11,16-17,19-20,22H,5-9,12-15H2,1-4H3,(H,30,36)(H,29,31,32)/t22-/m1/s1 | PDB
NCI pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 16.8 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Pfizer
| Assay Description Percent inhibition and IC50 values were determined with ATP concentrations at apparent Km using the Invitrogen SelectScreen Kinase Profiling Service ... |
Chem Biol Drug Des 70: 540-6 (2007)
Article DOI: 10.1111/j.1747-0285.2007.00594.x BindingDB Entry DOI: 10.7270/Q2T151Z8 |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323420
(CHEMBL1209343 | N-(2-(3-(3-tert-butyl-5-(3-phenylu...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)CNC(=O)c2ccco2)c1 Show InChI InChI=1S/C28H30N6O4/c1-28(2,3)23-16-24(32-27(37)31-20-10-5-4-6-11-20)34(33-23)21-12-7-9-19(15-21)17-29-25(35)18-30-26(36)22-13-8-14-38-22/h4-16H,17-18H2,1-3H3,(H,29,35)(H,30,36)(H2,31,32,37) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323431
(CHEMBL1209564 | N-(3-(3-tert-butyl-5-(3-phenylurei...)Show SMILES Cc1ccn(CC(=O)NCc2cccc(c2)-n2nc(cc2NC(=O)Nc2ccccc2)C(C)(C)C)n1 Show InChI InChI=1S/C27H31N7O2/c1-19-13-14-33(31-19)18-25(35)28-17-20-9-8-12-22(15-20)34-24(16-23(32-34)27(2,3)4)30-26(36)29-21-10-6-5-7-11-21/h5-16H,17-18H2,1-4H3,(H,28,35)(H2,29,30,36) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 27.9 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323435
((1R)-2-(3-(3-tert-butyl-5-(3-phenylureido)-1H-pyra...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)C2C[C@H]2C(O)=O)c1 |r| Show InChI InChI=1S/C26H29N5O4/c1-26(2,3)21-14-22(29-25(35)28-17-9-5-4-6-10-17)31(30-21)18-11-7-8-16(12-18)15-27-23(32)19-13-20(19)24(33)34/h4-12,14,19-20H,13,15H2,1-3H3,(H,27,32)(H,33,34)(H2,28,29,35)/t19?,20-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323416
(2-acetamido-N-(3-(3-tert-butyl-5-(3-phenylureido)-...)Show SMILES CC(=O)NCC(=O)NCc1cccc(c1)-n1nc(cc1NC(=O)Nc1ccccc1)C(C)(C)C Show InChI InChI=1S/C25H30N6O3/c1-17(32)26-16-23(33)27-15-18-9-8-12-20(13-18)31-22(14-21(30-31)25(2,3)4)29-24(34)28-19-10-6-5-7-11-19/h5-14H,15-16H2,1-4H3,(H,26,32)(H,27,33)(H2,28,29,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of active p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323433
(4-(3-(3-tert-butyl-5-(3-phenylureido)-1H-pyrazol-1...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)CCC(O)=O)c1 Show InChI InChI=1S/C25H29N5O4/c1-25(2,3)20-15-21(28-24(34)27-18-9-5-4-6-10-18)30(29-20)19-11-7-8-17(14-19)16-26-22(31)12-13-23(32)33/h4-11,14-15H,12-13,16H2,1-3H3,(H,26,31)(H,32,33)(H2,27,28,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 37 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323419
(CHEMBL1209342 | N-(2-(3-(3-tert-butyl-5-(3-phenylu...)Show SMILES Cc1cc(no1)C(=O)NCC(=O)NCc1cccc(c1)-n1nc(cc1NC(=O)Nc1ccccc1)C(C)(C)C Show InChI InChI=1S/C28H31N7O4/c1-18-13-22(34-39-18)26(37)30-17-25(36)29-16-19-9-8-12-21(14-19)35-24(15-23(33-35)28(2,3)4)32-27(38)31-20-10-6-5-7-11-20/h5-15H,16-17H2,1-4H3,(H,29,36)(H,30,37)(H2,31,32,38) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323434
(4-(3-(3-tert-butyl-5-(3-phenylureido)-1H-pyrazol-1...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)CC(C)(C)C(O)=O)c1 Show InChI InChI=1S/C27H33N5O4/c1-26(2,3)21-15-22(30-25(36)29-19-11-7-6-8-12-19)32(31-21)20-13-9-10-18(14-20)17-28-23(33)16-27(4,5)24(34)35/h6-15H,16-17H2,1-5H3,(H,28,33)(H,34,35)(H2,29,30,36) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323430
(CHEMBL1209563 | N-(3-(3-tert-butyl-5-(3-phenylurei...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)Cn2cccn2)c1 Show InChI InChI=1S/C26H29N7O2/c1-26(2,3)22-16-23(30-25(35)29-20-10-5-4-6-11-20)33(31-22)21-12-7-9-19(15-21)17-27-24(34)18-32-14-8-13-28-32/h4-16H,17-18H2,1-3H3,(H,27,34)(H2,29,30,35) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 48.8 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323418
(CHEMBL1209276 | N-(2-(3-(3-tert-butyl-5-(3-phenylu...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)CNC(=O)c2cccnc2)c1 Show InChI InChI=1S/C29H31N7O3/c1-29(2,3)24-16-25(34-28(39)33-22-11-5-4-6-12-22)36(35-24)23-13-7-9-20(15-23)17-31-26(37)19-32-27(38)21-10-8-14-30-18-21/h4-16,18H,17,19H2,1-3H3,(H,31,37)(H,32,38)(H2,33,34,39) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 51 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323436
((1R)-2-(3-(3-tert-butyl-5-(3-phenylureido)-1H-pyra...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)C2CCCC[C@H]2C(O)=O)c1 |r| Show InChI InChI=1S/C29H35N5O4/c1-29(2,3)24-17-25(32-28(38)31-20-11-5-4-6-12-20)34(33-24)21-13-9-10-19(16-21)18-30-26(35)22-14-7-8-15-23(22)27(36)37/h4-6,9-13,16-17,22-23H,7-8,14-15,18H2,1-3H3,(H,30,35)(H,36,37)(H2,31,32,38)/t22?,23-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 57 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323427
(CHEMBL1209482 | N-(3-(3-tert-butyl-5-(3-phenylurei...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)Cn2ccccc2=O)c1 Show InChI InChI=1S/C28H30N6O3/c1-28(2,3)23-17-24(31-27(37)30-21-11-5-4-6-12-21)34(32-23)22-13-9-10-20(16-22)18-29-25(35)19-33-15-8-7-14-26(33)36/h4-17H,18-19H2,1-3H3,(H,29,35)(H2,30,31,37) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 63 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of active p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323415
(CHEMBL1209273 | N-(3-(3-tert-butyl-5-(3-phenylurei...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)CNC=O)c1 Show InChI InChI=1S/C24H28N6O3/c1-24(2,3)20-13-21(28-23(33)27-18-9-5-4-6-10-18)30(29-20)19-11-7-8-17(12-19)14-26-22(32)15-25-16-31/h4-13,16H,14-15H2,1-3H3,(H,25,31)(H,26,32)(H2,27,28,33) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL KEGG PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 68 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323425
(CHEMBL1209407 | N-(3-(3-tert-butyl-5-(3-phenylurei...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)CN2CCCC2=O)c1 Show InChI InChI=1S/C27H32N6O3/c1-27(2,3)22-16-23(30-26(36)29-20-10-5-4-6-11-20)33(31-22)21-12-7-9-19(15-21)17-28-24(34)18-32-14-8-13-25(32)35/h4-7,9-12,15-16H,8,13-14,17-18H2,1-3H3,(H,28,34)(H2,29,30,36) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 68 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323432
(CHEMBL1209565 | N-(3-(3-tert-butyl-5-(3-phenylurei...)Show SMILES Cc1cc(C)n(CC(=O)NCc2cccc(c2)-n2nc(cc2NC(=O)Nc2ccccc2)C(C)(C)C)n1 Show InChI InChI=1S/C28H33N7O2/c1-19-14-20(2)34(32-19)18-26(36)29-17-21-10-9-13-23(15-21)35-25(16-24(33-35)28(3,4)5)31-27(37)30-22-11-7-6-8-12-22/h6-16H,17-18H2,1-5H3,(H,29,36)(H2,30,31,37) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 78.2 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323420
(CHEMBL1209343 | N-(2-(3-(3-tert-butyl-5-(3-phenylu...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)CNC(=O)c2ccco2)c1 Show InChI InChI=1S/C28H30N6O4/c1-28(2,3)23-16-24(32-27(37)31-20-10-5-4-6-11-20)34(33-23)21-12-7-9-19(15-21)17-29-25(35)18-30-26(36)22-13-8-14-38-22/h4-16H,17-18H2,1-3H3,(H,29,35)(H,30,36)(H2,31,32,37) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 88 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of active p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323423
(CHEMBL1209405 | N-(3-(3-tert-butyl-5-(3-phenylurei...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)CNS(C)(=O)=O)c1 Show InChI InChI=1S/C24H30N6O4S/c1-24(2,3)20-14-21(28-23(32)27-18-10-6-5-7-11-18)30(29-20)19-12-8-9-17(13-19)15-25-22(31)16-26-35(4,33)34/h5-14,26H,15-16H2,1-4H3,(H,25,31)(H2,27,28,32) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 108 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323429
(CHEMBL1209484 | N-(3-(3-tert-butyl-5-(3-phenylurei...)Show SMILES Cc1nccn1CC(=O)NCc1cccc(c1)-n1nc(cc1NC(=O)Nc1ccccc1)C(C)(C)C Show InChI InChI=1S/C27H31N7O2/c1-19-28-13-14-33(19)18-25(35)29-17-20-9-8-12-22(15-20)34-24(16-23(32-34)27(2,3)4)31-26(36)30-21-10-6-5-7-11-21/h5-16H,17-18H2,1-4H3,(H,29,35)(H2,30,31,36) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 132 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323430
(CHEMBL1209563 | N-(3-(3-tert-butyl-5-(3-phenylurei...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)Cn2cccn2)c1 Show InChI InChI=1S/C26H29N7O2/c1-26(2,3)22-16-23(30-25(35)29-20-10-5-4-6-11-20)33(31-22)21-12-7-9-19(15-21)17-27-24(34)18-32-14-8-13-28-32/h4-16H,17-18H2,1-3H3,(H,27,34)(H2,29,30,35) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 135 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of active p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Serine/threonine-protein kinase PLK1
(Homo sapiens (Human)) | BDBM26515
(1-[4-(cyclopentylamino)-2-{[2-methoxy-4-(4-methylp...)Show SMILES COc1cc(ccc1Nc1ncc(C(C)=O)c(NC2CCCC2)n1)N1CCN(C)CC1 Show InChI InChI=1S/C23H32N6O2/c1-16(30)19-15-24-23(27-22(19)25-17-6-4-5-7-17)26-20-9-8-18(14-21(20)31-3)29-12-10-28(2)11-13-29/h8-9,14-15,17H,4-7,10-13H2,1-3H3,(H2,24,25,26,27) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 145 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Pfizer
| Assay Description Percent inhibition and IC50 values were determined with ATP concentrations at apparent Km using the Invitrogen SelectScreen Kinase Profiling Service ... |
Chem Biol Drug Des 70: 540-6 (2007)
Article DOI: 10.1111/j.1747-0285.2007.00594.x BindingDB Entry DOI: 10.7270/Q2T151Z8 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323421
(2-acetamido-N-(3-(3-tert-butyl-5-(3-phenylureido)-...)Show SMILES CC(NC(C)=O)C(=O)NCc1cccc(c1)-n1nc(cc1NC(=O)Nc1ccccc1)C(C)(C)C Show InChI InChI=1S/C26H32N6O3/c1-17(28-18(2)33)24(34)27-16-19-10-9-13-21(14-19)32-23(15-22(31-32)26(3,4)5)30-25(35)29-20-11-7-6-8-12-20/h6-15,17H,16H2,1-5H3,(H,27,34)(H,28,33)(H2,29,30,35) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 168 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323417
(CHEMBL1209275 | N-(2-(3-(3-tert-butyl-5-(3-phenylu...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)CNC(=O)c2ccccc2)c1 Show InChI InChI=1S/C30H32N6O3/c1-30(2,3)25-18-26(34-29(39)33-23-14-8-5-9-15-23)36(35-25)24-16-10-11-21(17-24)19-31-27(37)20-32-28(38)22-12-6-4-7-13-22/h4-18H,19-20H2,1-3H3,(H,31,37)(H,32,38)(H2,33,34,39) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 169 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323413
(2-amino-N-(3-(3-tert-butyl-5-(3-phenylureido)-1H-p...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)CN)c1 Show InChI InChI=1S/C23H28N6O2/c1-23(2,3)19-13-20(27-22(31)26-17-9-5-4-6-10-17)29(28-19)18-11-7-8-16(12-18)15-25-21(30)14-24/h4-13H,14-15,24H2,1-3H3,(H,25,30)(H2,26,27,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 176 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323414
(CHEMBL1209214 | methyl 2-(3-(3-tert-butyl-5-(3-phe...)Show SMILES COC(=O)NCC(=O)NCc1cccc(c1)-n1nc(cc1NC(=O)Nc1ccccc1)C(C)(C)C Show InChI InChI=1S/C25H30N6O4/c1-25(2,3)20-14-21(29-23(33)28-18-10-6-5-7-11-18)31(30-20)19-12-8-9-17(13-19)15-26-22(32)16-27-24(34)35-4/h5-14H,15-16H2,1-4H3,(H,26,32)(H,27,34)(H2,28,29,33) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 176 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323426
(CHEMBL1209481 | N-(3-(3-tert-butyl-5-(3-phenylurei...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)CN2CCOC2=O)c1 Show InChI InChI=1S/C26H30N6O4/c1-26(2,3)21-15-22(29-24(34)28-19-9-5-4-6-10-19)32(30-21)20-11-7-8-18(14-20)16-27-23(33)17-31-12-13-36-25(31)35/h4-11,14-15H,12-13,16-17H2,1-3H3,(H,27,33)(H2,28,29,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 185 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323431
(CHEMBL1209564 | N-(3-(3-tert-butyl-5-(3-phenylurei...)Show SMILES Cc1ccn(CC(=O)NCc2cccc(c2)-n2nc(cc2NC(=O)Nc2ccccc2)C(C)(C)C)n1 Show InChI InChI=1S/C27H31N7O2/c1-19-13-14-33(31-19)18-25(35)28-17-20-9-8-12-22(15-20)34-24(16-23(32-34)27(2,3)4)30-26(36)29-21-10-6-5-7-11-21/h5-16H,17-18H2,1-4H3,(H,28,35)(H2,29,30,36) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 201 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of active p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323418
(CHEMBL1209276 | N-(2-(3-(3-tert-butyl-5-(3-phenylu...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)CNC(=O)c2cccnc2)c1 Show InChI InChI=1S/C29H31N7O3/c1-29(2,3)24-16-25(34-28(39)33-22-11-5-4-6-12-22)36(35-24)23-13-7-9-20(15-23)17-31-26(37)19-32-27(38)21-10-8-14-30-18-21/h4-16,18H,17,19H2,1-3H3,(H,31,37)(H,32,38)(H2,33,34,39) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 205 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of active p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323424
(2-acetamido-N-(3-(3-tert-butyl-5-(3-phenylureido)-...)Show SMILES CN(Cc1cccc(c1)-n1nc(cc1NC(=O)Nc1ccccc1)C(C)(C)C)C(=O)CNC(C)=O Show InChI InChI=1S/C26H32N6O3/c1-18(33)27-16-24(34)31(5)17-19-10-9-13-21(14-19)32-23(15-22(30-32)26(2,3)4)29-25(35)28-20-11-7-6-8-12-20/h6-15H,16-17H2,1-5H3,(H,27,33)(H2,28,29,35) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 211 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323428
(CHEMBL1209483 | N-(3-(3-tert-butyl-5-(3-phenylurei...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)Cn2ccnc2)c1 Show InChI InChI=1S/C26H29N7O2/c1-26(2,3)22-15-23(30-25(35)29-20-9-5-4-6-10-20)33(31-22)21-11-7-8-19(14-21)16-28-24(34)17-32-13-12-27-18-32/h4-15,18H,16-17H2,1-3H3,(H,28,34)(H2,29,30,35) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 231 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of unactive p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323419
(CHEMBL1209342 | N-(2-(3-(3-tert-butyl-5-(3-phenylu...)Show SMILES Cc1cc(no1)C(=O)NCC(=O)NCc1cccc(c1)-n1nc(cc1NC(=O)Nc1ccccc1)C(C)(C)C Show InChI InChI=1S/C28H31N7O4/c1-18-13-22(34-39-18)26(37)30-17-25(36)29-16-19-9-8-12-21(14-19)35-24(15-23(33-35)28(2,3)4)32-27(38)31-20-10-6-5-7-11-20/h5-15H,16-17H2,1-4H3,(H,29,36)(H,30,37)(H2,31,32,38) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 243 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of active p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Hematopoietic prostaglandin D synthase
(Homo sapiens (Human)) | BDBM50385143
(CHEMBL2035652)Show InChI InChI=1S/C18H21N3O2/c22-18(20-9-10-21-11-13-23-14-12-21)16-6-4-15(5-7-16)17-3-1-2-8-19-17/h1-8H,9-14H2,(H,20,22) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 274 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of human recombinant HPGDS using PGH2 as substrate assessed as production of PGD2 preincubated for 10 mins prior substrate addition measur... |
Bioorg Med Chem Lett 22: 3795-9 (2012)
Article DOI: 10.1016/j.bmcl.2012.04.004 BindingDB Entry DOI: 10.7270/Q28C9X82 |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Hematopoietic prostaglandin D synthase
(Homo sapiens (Human)) | BDBM50385149
(CHEMBL2035649)Show SMILES O=C(Nc1ccc(cc1)N1CCN(CC1)C(=O)N1CCOCC1)c1cnc(Oc2ccccc2)nc1 Show InChI InChI=1S/C26H28N6O4/c33-24(20-18-27-25(28-19-20)36-23-4-2-1-3-5-23)29-21-6-8-22(9-7-21)30-10-12-31(13-11-30)26(34)32-14-16-35-17-15-32/h1-9,18-19H,10-17H2,(H,29,33) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 280 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of HPGDS |
Bioorg Med Chem Lett 22: 3795-9 (2012)
Article DOI: 10.1016/j.bmcl.2012.04.004 BindingDB Entry DOI: 10.7270/Q28C9X82 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323414
(CHEMBL1209214 | methyl 2-(3-(3-tert-butyl-5-(3-phe...)Show SMILES COC(=O)NCC(=O)NCc1cccc(c1)-n1nc(cc1NC(=O)Nc1ccccc1)C(C)(C)C Show InChI InChI=1S/C25H30N6O4/c1-25(2,3)20-14-21(29-23(33)28-18-10-6-5-7-11-18)31(30-20)19-12-8-9-17(13-19)15-26-22(32)16-27-24(34)35-4/h5-14H,15-16H2,1-4H3,(H,26,32)(H,27,34)(H2,28,29,33) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 287 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of active p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323425
(CHEMBL1209407 | N-(3-(3-tert-butyl-5-(3-phenylurei...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)CN2CCCC2=O)c1 Show InChI InChI=1S/C27H32N6O3/c1-27(2,3)22-16-23(30-26(36)29-20-10-5-4-6-11-20)33(31-22)21-12-7-9-19(15-21)17-28-24(34)18-32-14-8-13-25(32)35/h4-7,9-12,15-16H,8,13-14,17-18H2,1-3H3,(H,28,34)(H2,29,30,36) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 296 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of active p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323432
(CHEMBL1209565 | N-(3-(3-tert-butyl-5-(3-phenylurei...)Show SMILES Cc1cc(C)n(CC(=O)NCc2cccc(c2)-n2nc(cc2NC(=O)Nc2ccccc2)C(C)(C)C)n1 Show InChI InChI=1S/C28H33N7O2/c1-19-14-20(2)34(32-19)18-26(36)29-17-21-10-9-13-23(15-21)35-25(16-24(33-35)28(3,4)5)31-27(37)30-22-11-7-6-8-12-22/h6-16H,17-18H2,1-5H3,(H,29,36)(H2,30,31,37) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 331 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of active p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50323415
(CHEMBL1209273 | N-(3-(3-tert-butyl-5-(3-phenylurei...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(n1)-c1cccc(CNC(=O)CNC=O)c1 Show InChI InChI=1S/C24H28N6O3/c1-24(2,3)20-13-21(28-23(33)27-18-9-5-4-6-10-18)30(29-20)19-11-7-8-17(12-19)14-26-22(32)15-25-16-31/h4-13,16H,14-15H2,1-3H3,(H,25,31)(H,26,32)(H2,27,28,33) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL KEGG PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 332 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of active p38alpha |
Bioorg Med Chem Lett 20: 4885-91 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.073 BindingDB Entry DOI: 10.7270/Q2Z31ZT2 |
More data for this Ligand-Target Pair | |
Serine/threonine-protein kinase PLK1
(Homo sapiens (Human)) | BDBM26516
(1-[4-(cyclopentylamino)-2-{[4-(4-methylpiperazin-1...)Show SMILES CN1CCN(CC1)c1ccc(Nc2ncc(C(C)=O)c(NC3CCCC3)n2)cc1 Show InChI InChI=1S/C22H30N6O/c1-16(29)20-15-23-22(26-21(20)24-17-5-3-4-6-17)25-18-7-9-19(10-8-18)28-13-11-27(2)12-14-28/h7-10,15,17H,3-6,11-14H2,1-2H3,(H2,23,24,25,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 345 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Pfizer
| Assay Description Percent inhibition and IC50 values were determined with ATP concentrations at apparent Km using the Invitrogen SelectScreen Kinase Profiling Service ... |
Chem Biol Drug Des 70: 540-6 (2007)
Article DOI: 10.1111/j.1747-0285.2007.00594.x BindingDB Entry DOI: 10.7270/Q2T151Z8 |
More data for this Ligand-Target Pair | |